相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。PCV13 Vaccination of Adults against Pneumococcal Disease: What We Have Learned from the Community-Acquired Pneumonia Immunization Trial in Adults (CAPiTA)
Christian Theilacker et al.
MICROORGANISMS (2022)
Response to Vyse et al., A review of current data to support decision making for introduction of next generation higher valency pneumococcal conjugate vaccination of immunocompetent older adults in the UK
Rachel Dawson et al.
EXPERT REVIEW OF VACCINES (2022)
Rapid increase in non-vaccine serotypes causing invasive pneumococcal disease in England and Wales, 2000-17: a prospective national observational cohort study
Shamez N. Ladhani et al.
LANCET INFECTIOUS DISEASES (2018)
Effectiveness of 23-Valent Polysaccharide Pneumococcal Vaccine and Changes in Invasive Pneumococcal Disease Incidence from 2000 to 2017 in Those Aged 65 and Over in England andWales
Abdelmajid Djennad et al.
ECLINICALMEDICINE (2018)
Cost-Effectiveness of Vaccinating Immunocompetent ≥65 Year Olds with the 13-Valent Pneumococcal Conjugate Vaccine in England
Albert Jan van Hoek et al.
PLOS ONE (2016)
Impact and effectiveness of 23-valent pneumococcal polysaccharide vaccine against invasive pneumococcal disease in the elderly in England and Wales
Nick J. Andrews et al.
VACCINE (2012)